Caring Brands Inc

Caring Brands Inc(CABR)の株式分析

$1.390

+0.010 (+0.72%)終値時点

Loading chart…
High
1.419
Open
1.380
VWAP
1.38
Vol
21.26K
Mkt Cap
Low
1.340
Amount
29.40K
EV/EBITDA, TTM
0.00

Caring Brands, Inc. is a wellness consumer products company. The Company offers several over-the-counter (OTC), and cosmetic, consumer products. Its product pipeline includes a diverse range of products, such as hair-loss treatments, eczema and psoriasis treatments, vitiligo solutions, Jellyfish sting protective suncare line and women’s sexual wellness products that cater to different health and wellness needs. Its hair loss product, Hair Enzyme Booster, is designed to improve Minoxidil efficacy and is available as a topical solution. Its Photocil is used to treat vitiligo and psoriasis. Photocil is a cosmetic product designed to block certain ultraviolet (UV) radiation while allowing other UV radiation to pass through when applied to the skin. NoStingz is used for topical protection from jellyfish, sea lice, and Ultraviolet A radiation/ Ultraviolet B radiation (UVA/UVB) rays. JW-100 is used for the topical treatment of atopic dermatitis (eczema).

AI analysis of Caring Brands Inc (CABR)

hold

Caring Brands Inc (CABR) is currently trading at $1.39, which is a 39% increase year-to-date, indicating some positive momentum. However, the company has reported a significant net loss of over $4 million in the last quarter, which raises concerns about its financial health. The RSI is at 55.98, suggesting it is neither overbought nor oversold, and the stock has shown a recent 5-day change of +7.75%, indicating short-term strength. The main risk is the company's negative earnings per share (EPS) of -0.10 reported last quarter, which reflects ongoing financial struggles. Therefore, while there are some positive indicators, the substantial losses and lack of profitability suggest it may be prudent to hold off on buying until there are clearer signs of recovery.

バリュエーション指標

The current forward P/E ratio for Caring Brands Inc (CABR) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
割高
0.00
割安
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
割高
0.00
割安
0.00

Forward P/S

Fair
5Y Average P/S
0.01
Current P/S
0.00
割高
0.14
割安
-0.11

イベントタイムライン

2026-06-01 (ET)

09:10:00

Caring Brands and SanPellegrino Sign New Licensing Agreement

2026-05-06 (ET)

06:20:00

Caring Brands Files to Sell 18.95M Shares of Common Stock

2026-02-03 (ET)

08:40:00

Caring Brands Secures Two New US Patents

2026-01-05 (ET)

08:50:00

Caring Brands Enters Exclusive License Agreement with Itonis

ニュース

CABR FAQ — answered by Alphio AI

Caring Brands, Inc. is a wellness consumer products company. The Company offers several over-the-counter (OTC), and cosmetic, consumer products. Its product pipeline includes a diverse range of products, such as hair-loss treatments, eczema and psoriasis treatments, vitiligo solutions, Jellyfish sting protective suncare line and women’s sexual wellness products that cater to different health and wellness needs. Its hair loss product, Hair Enzyme Booster, is designed to improve Minoxidil efficacy and is available as a topical solution. Its Photocil is used to treat vitiligo and psoriasis. Photocil is a cosmetic product designed to block certain ultraviolet (UV) radiation while allowing other UV radiation to pass through when applied to the skin. NoStingz is used for topical protection from jellyfish, sea lice, and Ultraviolet A radiation/ Ultraviolet B radiation (UVA/UVB) rays. JW-100 is used for the topical treatment of atopic dermatitis (eczema). It operates in the Consumer Non-Cyclicals sector.

Caring Brands Inc (CABR) is currently trading at $1.39, which is a 39% increase year-to-date, indicating some positive momentum. However, the company has reported a significant net loss of over $4 million in the last quarter, which raises concerns about its financial health. The RSI is at 55.98, suggesting it is neither overbought nor oversold, and the stock has shown a recent 5-day change of +7.75%, indicating short-term strength. The main risk is the company's negative earnings per share (EPS) of -0.10 reported last quarter, which reflects ongoing financial struggles. Therefore, while there are some positive indicators, the substantial losses and lack of profitability suggest it may be prudent to hold off on buying until there are clearer signs of recovery.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める